Your browser doesn't support javascript.
loading
Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study.
Abraham, Adith; Barcenas, Carlos H; Bleicher, Richard J; Cohen, Adam L; Javid, Sara H; Levine, Ellis G; Lin, Nancy U; Moy, Beverly; Niland, Joyce C; Wolff, Antonio C; Hassett, Michael J; Asad, Sarah; Stover, Daniel G.
Afiliação
  • Abraham A; Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Barcenas CH; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bleicher RJ; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Cohen AL; University of Utah, Salt Lake City, UT, USA.
  • Javid SH; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Levine EG; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Lin NU; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Moy B; Massachusetts General Hospital, Boston, MA, USA.
  • Niland JC; City of Hope Duarte, CA, USA.
  • Wolff AC; Johns Hopkins University, Baltimore, MD, USA.
  • Hassett MJ; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Asad S; Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Stover DG; Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: daniel.stover@osumc.edu.
Breast ; 67: 89-93, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36681001
ABSTRACT

BACKGROUND:

Most metastatic recurrences of triple negative breast cancer (TNBC) occur within five years of diagnosis, yet late relapses of TNBC (lrTNBC) do occur. Our objective was to develop a risk prediction model of lrTNBC using readily available clinicopathologic and sociodemographic features.

METHODS:

We included patients diagnosed with stage I-III TNBC between 1998 and 2012 at ten academic cancer centers. lrTNBC was defined as relapse or mortality greater than 5 years from diagnosis. Features associated with lrTNBC were included in a multivariable logistic model using backward elimination with a p < 0.10 criterion, with a final multivariable model applied to training (70%) and independent validation (30%) cohorts.

RESULTS:

A total 2210 TNBC patients with at least five years follow-up and no relapse before 5 years were included. In final multivariable model, lrTNBC was significantly associated with higher stage at diagnosis (adjusted Odds Ratio [aOR] for stage III vs I, 10.9; 95% Confidence Interval [CI], 7.5-15.9; p < 0.0001) and BMI (aOR for obese vs normal weight, 1.4; 95% CI, 1.0-1.8; p = 0.03). Final model performance was consistent between training (70%) and validation (30%) cohorts.

CONCLUSIONS:

A risk prediction model incorporating stage, BMI, and age at diagnosis offers potential utility for identification of patients at risk of development of lrTNBC and warrants further investigation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article